Fischer Medical Ventures Ltd (IN:FISCHER)
:FISCHER
Want to see IN:FISCHER full AI Analyst Report?
FISCHER Stock Chart & Stats
₹43.67
--
Market closed
₹43.67
--
Day’s Range― - ―
52-Week Range₹32.09 - ₹124.20
Previous CloseN/A
VolumeN/A
Average Volume (3M)267.56K
Market Cap
₹22.65B
Enterprise Value₹23.60B
Total Cash (Recent Filing)₹428.70M
Total Debt (Recent Filing)₹370.08M
Price to Earnings (P/E)35.3
Beta0.32
Next Earnings
Jun 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.01%
Share Statistics
EPS (TTM)0.22
Shares Outstanding648,515,440
10 Day Avg. Volume611,655
30 Day Avg. Volume267,556
Financial Highlights & Ratios
PEG Ratio-97.87
Price to Book (P/B)33.38
Price to Sales (P/S)101.77
P/FCF Ratio-121.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained revenue growth indicates the company is expanding its market traction and demand for its medical-device offerings. Over a 2–6 month horizon this supports scalability and revenue visibility, providing a base to improve margins if cost structure is addressed.
Low Leverage / Strong Capital StructureA low debt-to-equity ratio provides financial flexibility to fund operations, investments, or cushion downturns without immediate refinancing pressure. This conservative capital structure reduces solvency risk and supports strategic choices over multiple quarters.
Significant EPS ImprovementVery strong EPS growth signals meaningful improvement in reported earnings versus prior periods, which can reflect operational gains or leverage on revenue. If driven by sustainable operational changes, this enhances future cash generation and investor confidence over the medium term.
Bears Say
Negative Operating & Free Cash FlowPersistent negative operating and free cash flows indicate the business is not converting profits into cash, constraining internal funding for capex, R&D, or working capital. Even with low leverage, continued cash burn forces reliance on external financing and weakens long-term resilience.
Margin CompressionDeclining gross and net margins, alongside falling EBIT/EBITDA margins, point to cost pressure or pricing weakness that erodes core profitability. Sustained margin compression undermines free cash flow potential and makes long-term earnings improvement harder without structural changes.
Very Low Return On EquityAn ROE near zero shows shareholder capital is generating minimal returns, signaling inefficient capital deployment or depressed profitability. Over time, persistently low ROE reduces the company's ability to attract investment and fund organic growth from retained earnings.
Fischer Medical Ventures Ltd News
FISCHER FAQ
What was Fischer Medical Ventures Ltd’s price range in the past 12 months?
Fischer Medical Ventures Ltd lowest stock price was ₹32.09 and its highest was ₹124.20 in the past 12 months.
What is Fischer Medical Ventures Ltd’s market cap?
Fischer Medical Ventures Ltd’s market cap is ₹22.65B.
When is Fischer Medical Ventures Ltd’s upcoming earnings report date?
Fischer Medical Ventures Ltd’s upcoming earnings report date is Jun 01, 2026 which is in 9 days.
How were Fischer Medical Ventures Ltd’s earnings last quarter?
Fischer Medical Ventures Ltd released its earnings results on Feb 18, 2026. The company reported ₹0.297 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.297.
Is Fischer Medical Ventures Ltd overvalued?
According to Wall Street analysts Fischer Medical Ventures Ltd’s price is currently Overvalued.
Does Fischer Medical Ventures Ltd pay dividends?
Fischer Medical Ventures Ltd pays a Notavailable dividend of ₹0.005 which represents an annual dividend yield of 0.01%. See more information on Fischer Medical Ventures Ltd dividends here
What is Fischer Medical Ventures Ltd’s EPS estimate?
Fischer Medical Ventures Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Fischer Medical Ventures Ltd have?
Fischer Medical Ventures Ltd has 648,515,440 shares outstanding.
What happened to Fischer Medical Ventures Ltd’s price movement after its last earnings report?
Fischer Medical Ventures Ltd reported an EPS of ₹0.297 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Fischer Medical Ventures Ltd?
Currently, no hedge funds are holding shares in IN:FISCHER
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Fischer Medical Ventures Ltd
Fischer Medical Ventures Limited engages in the manufacture, distribution, leasing, and maintenance of medical equipment in India and internationally. Its product portfolio includes magnetic resonance imaging (MRI) systems; preventive health kiosks; e-health access points; software solutions; cancer, TB screening, and handheld x-ray; spincare technology; nutraceuticals from plant extracts; mental health solutions; contactless screening solutions; and CT scan systems, as well as preventive diagnostic devices and ancillary medical instruments. The company was formerly known as Fischer Chemic Limited and changed its name to Fischer Medical Ventures Limited in March 2024. Fischer Medical Ventures Limited was incorporated in 1993 and is headquartered in Chennai, India.
Technical Analysis
Aarti Pharmalabs Limited
―
Marksans Pharma Limited
―
Shilpa Medicare Limited
―
Strides Pharma Science Ltd
―
Thyrocare Technologies Ltd
―